Vivitrol

This page contains recent news articles, when available, and an overview of Vivitrol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Alkermes' Corporate Presentation to be Webcast at the UBS Global ...  -  16 Sep 2008
...to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Trading Markets (press release),

Alcohol Dependence Drug Prompts Warning  -  16 Sep 2008
...the US Food and Drug Administration (FDA) said it had received 196 reports of injection site reactions from the drug (Vivitrol, made by Alkermes Inc, Journal of American Medical Association (subscription),

Cephalon Receives Complete Response Letter Regarding Request For ...  -  16 Sep 2008
FENTORA, TRISENOX® (arsenic trioxide) injection, VIVITROL® (naltrexone for extended-release injectable suspension), GABITRIL® (tiagabine hydrochloride), Medical News Today (press release),

Vivitrol Causes Adverse Injection Site Reactions  -  Sep 11, 2008
The FDA notified doctors that Vivitrol has been shown to cause adverse injection site reactions. Vivitrol, also known as naltrexone, was approved by the FDA InjuryBoard.com,

FDA Warns of Injection Site Risks With Vivitrol  -  Aug 19, 2008
Vivitrol (naltrexone) is approved to treat alcohol dependence in patients who can abstain from alcohol in an outpatient setting before starting treatment. FDA news (subscription),

BUYINS.NET: (ALKS) SqueezeTrigger Price is $13.233. There is ...  -  Aug 28, 2008
VIVITROL (naltrexone for extended-release injectable suspension) is a once-monthly injection for the treatment of alcohol dependence and is marketed in the Trading Markets (press release),

FDA Warns About Injection Site Reactions With Naltrexone  -  Aug 18, 2008
Vivitrol is an opioid-receptor blocker administered once monthly by intramuscular gluteal injection for the treatment of alcoholism in patients able to RMGH Health News,

Local woman shares her story of addiction  -  Sep 12, 2008
Ulich takes a prescribed drug, Vivitrol, which eliminates the effects of opiate drugs. Ulich relies on the drug to help keep her from falling back into bad Abington Mariner,

Alcoholism in Hawaii to be House topic tomorrow  -  Aug 25, 2008
The committee will also review the efficacy of Vivitrol, a new medication taken by injection once a month that can be used in conjunction with a treatment Honolulu Advertiser,

알코올 해�?�제 Naltrexone 부작용 200건 접수  -  Aug 21, 2008
...미국�?서 Naltrexone�?� Alkermes사와 Cephalon사�?서 ‘Vivitrol’ �?표로 �?매하고 있다. 부작용�?� 봉와�?염, 경화�?, 혈종, 종기, 괴사 등으로 나타났으며, 메디�?�뉴스,

Alkermes Inc receives marketing approval for VIVITROL for alcohol ...  -  Aug 5, 2008
VIVITROL will be manufactured by Alkermes and commercialised by Janssen-Cilag, an affiliate company of Cilag GmbH International. Trading Markets (press release),

Alkermes Announces Approval Of VIVITROL(R) For The Treatment Of ...  -  Aug 6, 2008
..."VIVITROL is the first once-monthly injectable medication for the treatment of alcohol dependence to be approved in Russia. The long-acting, non-addictive Medical News Today (press release),

Alkermes's partner Cilag wins Russian approval for Vivitrol  -  Aug 6, 2008
Alkermes and Cilag have previously announced an exclusive agreement to commercialize Vivitrol for the treatment of alcohol and opioid dependence in Russia Trading Markets (press release),

Alkermes Announces First Quarter Fiscal 2009 Results and Raises ...  -  Aug 7, 2008
Manufacturing revenues for the quarter ended June 30, 2008 consisted of $36.0 million for RISPERDAL CONSTA and $2.6 million for VIVITROL ® , compared to Business Wire (press release),

Alkermes alcohol drug gets Russian approval  -  Aug 4, 2008
Russian regulatory authorities approved the marketing of Vivitrol, a once-monthly, extended-release injectable medication for the treatment of alcohol Boston Globe,

Alkermes enters Russian market with alcoholism drug  -  Aug 4, 2008
...based company (Nasdaq: ALKS) said Monday that Russian regulatory authorities have granted marketing approval for Vivitrol. The market potential in Russia is Bizjournals.com,

Should drinking age be lowered?  -  Aug 1, 2008
One is Vivitrol, which is an injectable form of Naltrexone. With Vivitrol, a person receives an injection once per month instead of having to take a pill Gloucester Daily Times,

Naltrexone Approved in Russia for Treatment of Alcohol Dependence  -  Aug 4, 2008
CAMBRIDGE, Mass -- August 4, 2008 -- The Russian Regulatory Authorities have approved naltrexone (VIVITROL) extended-release injectable suspension for the DG News

Alkermes to Host Conference Call to Discuss Financial Results for ...  -  Jul 31, 2008
...manufactures RISPERDAL ® CONSTA ® for schizophrenia and developed and manufactures VIVITROL ® for alcohol dependence. Alkermes’ robust pipeline includes Business Wire (press release),

Alkermes Presents Positive Preclinical Data On Naltrexone For ...  -  Jul 16, 2008
VIVITROL® is a registered trademark of Cephalon, Inc.; RISPERDAL® CONSTA® is a registered trademark of Janssen-Cilag group of companies. Medical News Today (press release),

Supplemental New Drug Application for RISPERDAL ® CONSTA ...  -  Jul 24, 2008
Medisorb is a registered trademark of Alkermes, Inc., VIVITROL is a registered trademark of Cephalon, Inc. and RISPERDAL CONSTA is a registered trademark of Business Wire (press release),

Aspen now Colorado outlet for a controversial new addiction treatment  -  Aug 3, 2008
Vivitrol, a short-term immunization that blocks alcohol's ability to work on the brain, has also been used with some success. But Ayers argues that Prometa, Aspen Times,

Cephalon Exceeds Both Sales and Earnings Guidance for Second ...  -  Jul 30, 2008
PROVIGIL(R) (modafinil) Tablets [C-IV], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), PharmaLive.com (press release),

InvestSource, Inc.: Road Wings' Funding Partner OneFi Technology ...  -  Aug 5, 2008
..."VIVITROL is the first once-monthly inject able medication for the treatment of alcohol dependence to be approved in Russia. The long-acting, non-addictive Trading Markets (press release),

Journal of Clinical Oncology Publishes Study of Cephalon ...  -  Jul 15, 2008
TREANDA, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), CNNMoney.com (press release)

Alkermes Presents Positive Preclinical Data on Naltrexone for ...  -  Jul 14, 2008
VIVITROL(R) is a registered trademark of Cephalon, Inc.; RISPERDAL(R) CONSTA(R) is a registered trademark of Janssen-Cilag group of companies. PharmaLive.com (press release),

A 50-Year-Old Woman Addicted to Heroin  -  Jul 15, 2008
Financial Disclosures: Dr O’Brien reports that he has received consulting fees from Alkermes Inc, the producer of the Vivitrol brand of depot naltrexone. Journal of American Medical Association (subscription),

SSTAR goes international  -  07 Jul 2008
SSTAR Executive Director Nancy Paull said the first visit will come on July 10, when the British group will learn about a drug called Vivitrol, Fall River Herald News,

A Thought Leader Analysis into Alcoholism and Future Competitive ...  -  07 Jul 2008
Drugs/classes mentioned in this report include: -- -ReVia (naltrexone) -- -Vivitrol (extended release injectable naltrexone -- -Alkermes / Cephalon) StreetInsider.com (subscription),

Alkermes Presents Positive Data on Proprietary Molecules Targeting ...  -  Jul 1, 2008
VIVITROL(R) is a registered trademark of Cephalon, Inc.; RISPERDAL(R) CONSTA(R) is a registered trademark of Janssen-Cilag group of companies. FOXBusiness

Alkermes Initiates Phase 3 Clinical Study of VIVITROL ® for the ...  -  Jun 26, 2008
The multi-center study is designed to assess the efficacy and safety of VIVITROL in approximately 200 patients diagnosed with opioid dependence. Business Wire (press release),

Alkermes Initiates Phase 3 Trials Of opiod drug VIVITROL  -  Jun 26, 2008
The US Food and Drug Administration approved VIVITROL in April 2006 for treatment of alcohol dependence. Cambridge, Massachusetts-based company noted that RTT News,

Anti-heroin drug buprenorphine is best for helping addicts: study  -  Jun 26, 2008
Buprenorphine, which is marketed as Temgesic or Buprenex, was twice as effective as naltrexone (branded as Revia, Depade or Vivitrol) and the placebo in AFP

2008-06-18 15:23:27 - www.companiesandmarkets.com adds new report ...  -  Jun 18, 2008
Companies developing naltrexone depot drugs will experience difficulty distinguishing their products from Vivitrol (naltrexone once-monthly PR-Inside.com (Pressemitteilung),

Alkermes shares rise on outlook for 2009 profit  -  Jun 16, 2008
...erosion of the Risperdal Consta royalty stream," he said in a note to investors. Alkermes is also developing Vivitrol as an alcohol dependence treatment. Forbes,

Alkermes (ALKS): Price cycles in bullish 'pennant' consolidation ...  -  Jun 18, 2008
The firm developed and manufactures Vivitrol, a treatment for alcohol dependence that partner Cephalon (NASDAQ: CEPH) markets in the United States. BloggingStocks

Cephalon Announces Issuance of Patent for AMRIX  -  Jun 17, 2008
TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), Earthtimes (press release),

After One Year, Type 2 Diabetes Patients Taking Exenatide Once ...  -  Jun 9, 2008
...to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. PR Newswire (press release),

Market Report -- In Play (WIRES)  -  Jun 26, 2008
Alkermes (ALKS) announces the initiation of a phase 3 clinical trial of VIVITROL for the treatment of opioid dependence. The multi-center study is designed MSN Money

Urges Of Pathological Gamblers Curbed By Drug Commonly Used For ...  -  Jun 16, 2008
An extended-release formulation is sold under the name Vivitrol. Article adapted by Medical News Today from original press release. Medical News Today (press release),

Cephalon Files Patent Infringement Lawsuit Against Watson ...  -  03 Jun 2008
TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), PR Newswire (press release),

Alkermes' Corporate Presentation to be Webcast at the Friedman ...  -  May 27, 2008
...to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. FOXBusiness

APA: Extended-Release Naltrexone (Vivitrol) Safe But Compliance ...  -  May 7, 2008
By John Gever, Staff Writer, MedPage Today WASHINGTON, May 7 -- Even taking extended-release naltrexone (Vivitrol) by injection once a month, MedPage Today,

Alkermes Reports Financial Results for Fiscal 2008 and Provides ...  -  May 23, 2008
Total manufacturing revenues for fiscal 2008 were $101.7 million, consisting of $95.2 million for RISPERDAL CONSTA and $6.5 million for VIVITROL(R), Barron's Blogs

Cephalon spent $512000 on lobbying in first quarter  -  May 16, 2008
The company markets the drug Vivitrol, a monthly injectable treatment for alcoholism. Along with Congress, Cephalon lobbied the Federal Trade Commission, Houston Chronicle,

Alkermes to Host Conference Call to Discuss Fiscal Year 2008 ...  -  May 15, 2008
...manufactures RISPERDAL ® CONSTA ® for schizophrenia and developed and manufactures VIVITROL ® for alcohol dependence. Alkermes’ robust pipeline includes Business Wire (press release),

2008-05-19 21:41:43 - http://www.companiesandmarkets.com adds new ...  -  May 19, 2008
Companies developing naltrexone depot drugs will experience difficulty distinguishing their products from Vivitrol (naltrexone once-monthly PR-Inside.com (Pressemitteilung),

Alkermes to Host Conference Call to Discuss Fiscal Year 2008 ...  -  May 15, 2008
...to improve patients lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. InfoBolsa,

Alkermes’ Corporate Presentation to be Webcast at the Bank of ...  -  May 8, 2008
...manufactures RISPERDAL ® CONSTA ® for schizophrenia and developed and manufactures VIVITROL ® for alcohol dependence. Alkermes’ robust pipeline includes Business Wire (press release),

BUYINS.NET: (ALKS) SqueezeTrigger Price is $14.348. There is ...  -  May 26, 2008
VIVITROL (naltrexone for extended-release injectable suspension) is a once-monthly injection for the treatment of alcohol dependence and is marketed in the Trading Markets (press release),

Cephalon Announces FDA Advisory Committee Recommendation Against ...  -  May 6, 2008
TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), Earthtimes (press release),

Despite Excessive Alcohol-Related Health Costs and Lost ...  -  Apr 17, 2008
Other medicines used to treat alcohol dependence, according to WebMD, include: Vivitrol (naltrexone), a once-monthly injection that interferes with the Atlantic Information Services, Inc.,

Supplemental New Drug Application for RISPERDAL ® CONSTA ...  -  Apr 14, 2008
Medisorb is a registered trademark of Alkermes, Inc., VIVITROL is a registered trademark of Cephalon, Inc. and RISPERDAL CONSTA is a registered trademark of Business Wire (press release),

New MedPredict Report Suggests Market for Alcoholism Therapies is ...  -  Apr 3, 2008
Drugs/classes mentioned in this report: ReVia (naltrexone); Vivitrol (extended release injectable naltrexone; Alkermes / Cephalon); Campral (acamprosate; FOXBusiness

Cephalon Announces European Commission Approval of EFFENTORA for ...  -  Apr 14, 2008
AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) PR Newswire UK (press release),

Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon ...  -  Mar 31, 2008
FENTORA® (fentanyl buccal tablet) [C-II], TRISENOX® (arsenic trioxide) injection, VIVITROL® (naltrexone for extended-release injectable suspension), Business Wire (press release),

Zacks Analyst Blog Highlights: Alkermes, Eli Lilly, Johnson ...  -  Mar 31, 2008
2008 will mark the initiation of the phase III opiate dependence study for Vivitrol, initiation of the marketing trials for Exenatide LAR and initiation of FOXBusiness

Alkermes Provides Update On Inhaled Insulin Program  -  Mar 10, 2008
AIR® is a registered trademark of Alkermes, Inc; VIVITROL® is a registered trademark of Cephalon, Inc.; and, RISPERDAL® CONSTA® is a registered trademark of Medical News Today (press release),

Lilly Ends Effort to Develop an Inhaled Insulin Product  -  Mar 8, 2008
Alkermes, which makes the alcohol addiction drug Vivitrol, said Lilly had the right to terminate its license to the inhaled treatment, Air Insulin, New York Times,

Alkermes says Lilly to drop out of insulin program  -  Mar 7, 2008
Cambridge, Massachusetts-based Alkermes, which makes the alcohol addiction drug Vivitrol, said Lilly has the right to terminate its license to AIR Insulin Reuters

Alcoholism drug market: shift in disease perception required for ...  -  Feb 18, 2008
There remains substantial opportunity for new drugs which are able to improve upon the effectiveness of Vivitrol (naltrexone, Alkermes/Cephalon), Trading Markets (press release),

Partner Expects Lilly to Discontinue Inhaled Insulin Program  -  Mar 7, 2008
...medicines to improve patients’ lives, manufactures RISPERDAL® CONSTA® for schizophrenia and developed and manufactures VIVITROL® for alcohol dependence. Inside INdiana Business (press release),

inVentiv Selling Solutions Selected to Provide Sales Team for ...  -  Mar 6, 2008
AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) SunHerald.com,

NEWSWEEK Cover: The Hunt for an Addiction Vaccine  -  Feb 25, 2008
..."We need four or five more years to see how [Vivitrol] does," says staff psychiatrist Garrett O'Conner at the Betty Ford Center, in Rancho Mirage, Calif., FOXBusiness

What Addicts Need  -  Feb 23, 2008
So when a family doctor told her about Vivitrol, a monthly injection that prevents patients from drinking alcohol by obliterating its ability to intoxicate, Newsweek

WellStep, Metro Atlanta Office-Based, Confidential Treatment ...  -  Feb 20, 2008
For those struggling with alcoholism, Vivitrol (naltexone) and Campral (acamprosate) may be prescribed. An innovative, personalized treatment approach Emediawire (press release),

Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended ...  -  Feb 14, 2008
AMRIX, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets PR Newswire (press release),

Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance  -  Feb 13, 2008
...extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R). PharmaLive.com (press release),

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.